• Science and Research

  Arrevus’s CF Oral Antibiotic ARV-1801 Receives FDA Orphan Drug Status

  Posted by Cystic Fibrosis News Moderator on February 27, 2020 at 9:18 am

  

  The U.S. FDA has granted orphan drug status to ARV-1801 (sodium fusidate tablets), an oral antibiotic developed by Arrevus for cystic fibrosis patients. Read more here.

  What do you think of this news?

  Cystic Fibrosis News Moderator replied 4 years, 9 months ago 0 Member · 0 Replies
• 0 Replies

Log In to Reply